Skip to main content

Table 1 Patients’ characteristics and clinical data

From: Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity

Parameter

Non-diabetic

Diabetic

Lean

Overweight

Obese

Lean

Overweight

Obese

Total number (N)

8

19

22

2

9

31

Male (N)

2

12

11

1

5

18

Female (N)

6

7

11

1

4

13

Age (years)

28–53

29–71

26–66

48–58

45–59

23–72

Body mass index (kg/m2)

23.035 ± 2.326

28.31 ± 1.081

34.383 ± 2.784

25.473 ± 0.338

28.130 ± 1.015

33.759 ± 2.561

Fat percentage (fat %)

29.757 ± 6.196

32.647 ± 4.998

39.011 ± 4.350

32.100 ± 6.223

33.050 ± 5.379

37.333 ± 5.035

Glucose (mmol/l)

5.096 ± 0.639

5.602 ± 1.559

5.424 ± 0.799

5.800 ± 0.424

8.578 ± 1.770

8.640 ± 2.930

Cholesterol (mmol/l)

5.313 ± 1.254

4.899 ± 0.773

5.233 ± 1.073

5.400 ± 2.546

4.816 ± 1.681

5.065 ± 1.236

High-density lipoprotein (mmol/l)

1.791 ± 0.477

1.219 ± 0.225

1.115 ± 0.235

1.135 ± 0.148

1.147 ± 0.411

1.129 ± 0.288

Low-density lipoprotein (mmol/l)

3.250 ± 1.046

3.147 ± 0.699

3.427 ± 0.942

3.700 ± 2.121

2.767 ± 1.391

3.013 ± 1.106

Triglycerides (mmol/l)

0.566 ± 0.216

1.215 ± 0.644

1.465 ± 0.821

1.245 ± 1.252

1.972 ± 0.880

1.913 ± 1.495

HbA1c (%)

5.688 ± 0.464

5.917 ± 1.65

5.863 ± 0.497

6.000 ± 0.283

7.544 ± 1.673

8.235 ± 1.506

Hypertension (N)

0

2

3

0

3

14

Hyperlipidemia (N)

0

0

2

0

2

3

Coronary artery disease (N)

0

0

1

0

1

1

Allergy (N)

0

0

1

0

0

2

Asthma (N)

0

1

0

0

0

3

Therapy

 

Nadolol, Lipitor, Aspirin

Concor, Lipitor, Aspirin, Diovan

Metfornin, Aspirin

Glucophage, Lipitor, Lantus, Zocor, Diovan, Metformin, Aspirin

NovoRapid, Lantus, Insulin, Aspirin, Concor, Zocor, Mixtard, Glucophage, Metformin, Capoten